StoryFunding
Nyxoah raises $95M equity financing plus $15M EIB loan to accelerate US Genio commercialization
Nyxoah completed a $95 million equity financing round with strong insider participation and anticipated the second tranche of a $15 million European Investment Bank loan, representing $110 million in aggregate new capital. The financing accelerates Genio's US commercial expansion following FDA approval and early strong adoption.
- $95M equity round closed June 2026 with participation from existing and new institutional investors
- European Investment Bank contributing $15M loan facility to support manufacturing scale-up
- Genio achieved 15% market share in early US adopter accounts within six months of launch
- 40 sales representatives deployed under experienced US commercial leadership team